Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | BMS 1Q: Opdivo Sales Down 10%, Announces Restructuring Initiative | ||
Fr | Pfizer's BEQVEZ Approved by FDA for Treatment of Adults with Hemophilia B | ||
Fr | Abzena Introduces Enhanced Bioassay Platform | ||
Do | Fujifilm & Predictive Oncology Tackle Protein Interference | ||
Do | Regeneron & Mammoth Partner on CRISPR Therapies | ||
Do | FDA Approves Utility Therapeutics' Pivya in UTIs | ||
Do | Actym Therapeutics Taps Industry Veteran as CEO | ||
Do | Multiply Labs and GenScript Partner to Automate Cell Isolation | ||
Do | Parexel, Palantir Expand AI Alliance | ||
Do | Ascend Taps Scott Law as COO | ||
Do | FibroBiologics Discusses Opportunities to Work with Charles River | ||
Mi | Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals | ||
Mi | Kühne Holding AG Agrees to Acquire Aenova Group | ||
Mi | BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design | ||
Mi | Moderna and OpenAI Join Forces to Transform Healthcare with AI | ||
Mi | CureVac Names New Chief Business Officer | ||
Mi | Hanmi, Merck Enter Clinical Collaboration & Supply Agreement | ||
Mi | Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs | ||
Di | Evotec Appoints Dr. Christian Wojczewski CEO | ||
Di | Sanofi's Rilzabrutinib Meets Primary Endpoint in ITP | ||
Di | Sygnature Discovery Names New Chief Scientific Officer | ||
Di | Particle Dynamics Names New Chief Financial Officer | ||
Di | SnapSlide Introduces No-Torque, Child-Resistant Caps | ||
Di | Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies | ||
Di | Vertex Obtains Exclusive License to TreeFrog's C-Stem Technology |